Ledger.Open graph →
SEC Form D · filed July 29, 2011

Foresight Biotherapeutics, Inc

Offering
$2.0M
Sold
$2.0M
Exemption
—
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

People & firms on this filing (4)

Michael Weiser · TRABUCO CANYON, CAExec · DirectorMichael Weiser · NEW YORK, NYExec · DirectorJason Stein · NEW YORK, NYExec · DirectorStephen Rocamboli · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗